Evidence map›Paper›PMID 24846381›Full record

ArticlemBio2014

Global adaptation to a lipid environment triggers the dormancy-related phenotype of Mycobacterium tuberculosis.

Juan G Rodríguez, Adriana C Hernández, Cecilia Helguera-Repetto, Diana Aguilar Ayala, Rosalina Guadarrama-Medina, Juan M Anzóla, Jose R Bustos, María M Zambrano, Jorge González-Y-Merchand, María J García and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in mBio, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Frontiers in microbiology · 2026
    Article
  10. Article
  11. Novel Populations ofMicroorganisms · 2024
    Article
  12. Regulatory role ofFrontiers in microbiology · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Antibiotics (Basel, Switzerland) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Juan G RodríguezDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia.
Adriana C HernándezDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia.
Cecilia Helguera-RepettoEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico Distrito Federal.
Diana Aguilar AyalaEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico Distrito Federal.
Rosalina Guadarrama-MedinaEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico Distrito Federal.
Juan M AnzólaDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia.
Jose R BustosDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia.
María M ZambranoDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia.
Jorge González-Y-MerchandEscuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional (IPN), Mexico Distrito Federal.
María J GarcíaDepartamento de Medicina Preventiva, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain pdelportillo@corpogen.org mariaj.garcia@uam.es.
Patricia Del PortilloDepartamento de Biotecnología Molecular y Genética Molecular, Corporación CorpoGen, Bogotá, Colombia pdelportillo@corpogen.org mariaj.garcia@uam.es.
CorpoGen (Colombia) · COInstituto Politécnico Nacional · MXUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledStrong evidence supports the idea that fatty acids rather than carbohydrates are the main energy source of Mycobacterium tuberculosis during infection and latency. Despite that important role, a complete scenario of the bacterium's metabolism when lipids are the main energy source is still lacking. Here we report the development of an in vitro model to analyze adaptation of M. tuberculosis during assimilation of long-chain fatty acids as sole carbon sources. The global lipid transcriptome revealed a shift toward the glyoxylate cycle, the overexpression of main regulators whiB3, dosR, and Rv0081, and the increased expression of several genes related to reductive stress. Our evidence showed that lipid storage seems to be the selected mechanism used by M. tuberculosis to ameliorate the assumed damage of reductive stress and that concomitantly the bacilli acquired a slowed-growth and drug-tolerant phenotype, all characteristics previously associated with the dormant stage. Additionally, intergenic regions were also detected, including the unexpected upregulation of tRNAs that suggest a new role for these molecules in the acquisition of a drug-tolerant phenotype by dormant bacilli. Finally, a set of lipid signature genes for the adaptation process was also identified. This in vitro model represents a suitable condition to illustrate the participation of reductive stress in drugs' activity against dormant bacilli, an aspect scarcely investigated to date. This approach provides a new perspective to the understanding of latent infection and suggests the participation of previously undetected molecules. IMPORTANCE: Mycobacterium tuberculosis establishes long-lasting highly prevalent infection inside the human body, called latent tuberculosis. The known involvement of fatty acids is changing our understanding of that silent infection; however, question of how tubercle bacilli globally adapt to a lipid-enriched environment is still an unanswered. With the single change of providing fatty acids as carbon sources, the bacilli switch on their program related to dormant stage: slowed growth, accumulation of lipid bodies, and development of drug tolerance. In this stage, unexpected and previously unknown participants were found to play putatively important roles during the process. For the first time, this work compares the global transcriptomics of bacteria by using strand-specific RNA sequencing under two different growth conditions. This study suggests novel targets for the control of tuberculosis and provides a new straightforward in vitro model that could help to test the activity of drugs against dormant bacilli from a novel perspective.

Indexed as

Adaptation, BiologicalGene-Environment InteractionLipid MetabolismPhenotypeCarbonEnergy MetabolismFatty AcidsGene Expression ProfilingGene Expression Regulation, BacterialModels, BiologicalMycobacterium tuberculosisCarbonFatty Acids

Identifiers

PMID24846381
PMCPMC4030484
OpenAlexW2144825193

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.